Location History:
- Yardley, PA (US) (2021)
- New York, NY (US) (2020 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: Laura Heckman: Innovator in Gene Therapy
Introduction
Laura Heckman is a prominent inventor based in New York, NY, known for her significant contributions to the field of gene therapy. With a total of 11 patents to her name, she has made remarkable strides in addressing neurodegenerative disorders through innovative therapeutic approaches.
Latest Patents
Heckman's latest patents include groundbreaking work on gene therapy for neurodegenerative disorders. This application is a continuation of international patent application serial number PCT/US2018/054223, filed on October 3, 2018. It claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application Ser. No. 62/567,303, also filed on October 3, 2017, entitled 'GENE THERAPIES FOR LYSOSOMAL DISORDERS'. Additionally, it references another provisional application, 62/567,305, filed on the same date, which is also focused on 'GENE THERAPIES FOR LYSOSOMAL DISORDERS'. These patents encompass compositions and methods for treating diseases associated with aberrant lysosomal function, such as fronto-temporal dementia (FTD). The disclosures provide expression constructs comprising a transgene encoding progranulin or a portion thereof, along with methods of treating FTD by administering such constructs to a subject in need.
Career Highlights
Heckman is currently associated with Prevail Therapeutics, Inc., where she continues to advance her research in gene therapy. Her work has been pivotal in developing innovative treatments that target complex neurological conditions, showcasing her dedication to improving patient outcomes.
Collaborations
Heckman collaborates with esteemed colleagues, including Asa Abeliovich and Herve Rhinn, who contribute to her research endeavors and enhance the impact of her work in the field of gene therapy.
Conclusion
Laura Heckman stands out as a leading inventor in the realm of gene therapy, with her innovative patents and collaborative efforts paving the way for advancements in treating neurodegenerative disorders. Her contributions are vital to the ongoing evolution of therapeutic strategies in this critical area of medicine.